Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review
  • Published Date:

    March 28 2019

  • Source:
    Eur J Contracept Reprod Health Care. 24(2):109-116
  • Language:
    English
Filetype[PDF-315.44 KB]


Details:
  • Alternative Title:
    Eur J Contracept Reprod Health Care
  • Description:
    Purpose To evaluate the association between postpartum hormonal contraceptive use and postpartum depression. Materials and methods We searched the literature through March 2018 on the association between postpartum hormonal contraception use and incident postpartum depression. We used the United States Preventive Services Task Force framework to assess study quality. Results Of 167 articles identified, four met inclusion criteria. Two studies found no differences in rates of postpartum depression between women using postpartum depot medroxyprogesterone and those not using hormonal contraception; however, a study of women receiving injectable norethisterone enanthate immediately postpartum found a 2–3-fold increased risk of depression at six weeks, though not at three months. One study compared combined hormonal contraception, progestin-only pills (POPs), etonogestrel implants and levonorgestrel intrauterine devices (LNG-IUDs) with no hormonal contraception, and found a 35–44% decreased risk of postpartum depression with POPs and LNG-IUDs, a small increased risk of postpartum antidepressant use among women using the etonogestrel implant and vaginal ring, and a decreased risk of antidepressant use with POPs. Conclusions Limited evidence found no consistent associations between hormonal contraceptive use and incidence of postpartum depression. Future research would be strengthened by using validated diagnostic measures, careful consideration of confounders, and ensuring adequate follow-up time.
  • Pubmed ID:
    30920314
  • Pubmed Central ID:
    PMC6541925
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: